Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension
Clinical trial NCT00872586 · COMPLETED
Trial details
- NCT number
- NCT00872586
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2007-07-01
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.